GALEN Partners III L P, 10% Owner at ACURA PHARMACEUTICALS, INC (ACUR), sold 183,434 shares at $2.21 ($427K) on 2013-05-13, disclosed to the SEC on 2013-05-15.
Open-market sale of $427k ACUR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.21 | 72,450 | $160K | 37.5% |
| 2 | $2.44 | 87,399 | $213K | 50.0% |
| 3 | $2.27 | 23,585 | $54K | 12.5% |
| Total | $2.33 avg | 183,434 | $427K | 100% |
| Filing → |
| ACUR | SELL | 2013-06-19 | $44K | — | Filing → |
| ACUR | SELL | 2013-06-03 | $71K | — | Filing → |
| ACUR | SELL | 2013-04-19 | $764K | — | Filing → |